NPM1 and acute myeloid leukemia: Simultaneously, profiting from slightly different oligomerization properties of NPMmut and NPMwt, a fine control of NPM oligomerization by appropriate concentrations of oligomerization-inhibiting drugs might have a therapeutic effect in the AML with NPM1 mutation.